GlassScriptPhysician profile
Haroon Mujahid
NPI 1841788114
$4,317.19
in general payments reported to CMS, 2019-2025
30 companies · $2,248 in 2025
The $2,248 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.40 · 2021: $46.70 · 2022: $823 · 2023: $819 · 2024: $368 · 2025: $2,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,401 · Travel and Lodging: $851 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,401.05 |
| Travel and Lodging | $850.57 |
| Education | $182.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,482.80 | 2022-2025 | Watchman Access System, Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $492.12 | 2023-2025 | Corevalve Evolut R, Resolute Onyx, Cobalt Dr Mri Surescan |
| Abiomed | $221.49 | 2024-2025 | Impella |
| Abbott Laboratories | $214.15 | 2022-2025 | Aveir, Perclose Proglide |
| Astrazeneca Pharmaceuticals LP | $193.47 | 2022-2025 | Wainua, Brilinta |
| Merck Sharp & Dohme LLC | $164.52 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.27 | 2023-2024 | Lifevest |
| Acist Medical Systems, INC. | $149.45 | 2023 | |
| Pfizer INC. | $132.80 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $132.29 | 2022-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.27 | 2022-2024 | Camzyos |
| Irhythm Technologies, INC. | $110.04 | 2022-2023 | Zio Xt Patch |
| Impulse Dynamics (USA) INC. | $103.62 | 2022-2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $78.73 | 2023-2024 | Uptravi, Opsumit |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $64.95 | 2024-2025 | Tyvaso, Tyvaso |
| Novartis Pharmaceuticals Corporation | $62.06 | 2023-2025 | |
| Angiodynamics, INC. | $52.57 | 2025 | Alphavac |
| Cardiva Medical, INC. | $46.91 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Bayer Healthcare Pharmaceuticals INC. | $37.24 | 2022 | |
| Procyrion, INC. | $34.05 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $21.85 | 2025 | Evkeeza |
| Bridgebio Pharma, INC. | $20.07 | 2025 | Attruby |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.01 | 2021 | |
| Edwards Lifesciences Corporation | $13.92 | 2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $13.48 | 2022 | |
| Scpharmaceuticals INC. | $13.47 | 2024 | |
| Novo Nordisk INC | $13.40 | 2020 | |
| Biotronik INC. | $13.35 | 2023 | Renamic Neo |
| Ucb, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haroon Mujahid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.